Provided By GlobeNewswire
Last update: May 12, 2025
PARIS and CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in fireside chats at following conference:
Read more at globenewswire.comNASDAQ:NBTX (6/12/2025, 8:14:21 PM)
5.76
+0.68 (+13.39%)
Find more stocks in the Stock Screener